OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.

Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.

Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.

Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.7 weeks; Submission to Acceptance: 17.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Aims

OBM Geriatrics (ISSN 2638-1311) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases. Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm. Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st-century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials. Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Scope

  • Geriatric biology
  • Geriatric health services research
  • Geriatric medicine research
  • Geriatric neurology, stroke, and cognition
  • Geriatric oncology
  • Geriatric surgery
  • Geriatric physical functioning, physical health, and activity
  • Geriatric psychiatry and psychology
  • Geriatric nutrition
  • Geriatric epidemiology
  • Geriatric rehabilitation

LIDSEN Publication Ethics Statement

OBM Geriatrics is a member of the Committee on Publication Ethics (COPE). We strictly adhere to the code of publication ethics set forth by COPE and deal with suspected ethical issues in accordance with its Core Practices.

Submitted articles are required to comply with Editorial Process and Quality Control, Research and Publication Ethics Guidelines, and Instructions for Authors, and rigorous and thorough peer review processes will be conducted to enforce high-quality articles. To verify the originality of content submitted to our journals, we ran an assay using iThenticate to check the similarity of submissions against previously published works. We are committed to ensuring that any potential ethical issues that are realized or pointed out, whether the manuscript is in the peer-review stage, has been accepted, or has been published, will be investigated and managed by following a standard process.

Copyright License and Open Access

Articles in OBM Geriatrics will be Open-Access published under the Creative Commons Attribution (CC BY 4.0) License, unless otherwise noted. Under this license, authors agree to make articles, including data, graphics, and supplements, legally available for reuse, without permission or fees, for virtually any purpose. Any individual or institution is free to copy, distribute, reproduce, or reuse these publications, as long as the author and original source are properly cited.

Please note that some articles (especially Reviews) may contain figures, tables or text taken from other publications, for which OBM Geriatrics does not hold the copyright or the right to re-license the published material. Please note that you should inquire with the original copyright holder (usually the original publisher or authors), whether or not this material can be re-used.


All the papers that are published in OBM Geriatrics contain a note:


https://www.lidsen.com/uploads/CCBY.png© 2024 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Announcement

Announcements regarding academic conferences are published for free in the Conferences section of the journal. Please contact us at geriatrics@lidsen.com.

Editorial Office

Ms. Cindy Dong
Managing Editor

For further OBM Geriatrics contacts, see here.

Newsletter

TOP